Skip to main content
SpringerLink
Log in

CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

CR3 (CD11b/CD18) functions both as an iC3b-receptor and as an adhesion molecule for cellular ligands such as ICAM-1. Although CR3 has been well characterized on phagocytic cells, much less is known about CR3 on lymphocytes. In this study, the expression of CR3 was examined on resting and stimulated B, T, and natural killer (NK) cells by three-color flow cytometry. Biotinylated anti-CR3 mAb and streptavidin-FITC were used in combination with anti-CD3 mAb conjugated with peridinin chlorophyll-a protein (PerCP) and phycoerythrinlabeled mAbs to CD4, CD8, CD19, or CD56. Among resting lymphocytes, CR3 was expressed on nearly all NK cells (CD56+CD3−), 1% of CD4+CD3+ helper T cells, 7% of CD8+CD3+ cytotoxic T cells, and 20% of B cells (CD19+). Among the 5% of T cells (CD3+) expressing CR3, the majority was CD56+. Incubation of PBMC for 30 min with PMA induced a three- to fivefold increase in CR3 expression on NK cells and a twofold increase on T cells but did not change the expression of CR3 on B cells. This effect of PMA was not blocked by the presence of cycloheximide, suggesting the presence of cytoplasmic (granule) stores of CR3 in these lymphoid cells resembling those previously reported in neutrophils and monocytes. When PBMC were incubated with rIFN-α, rIL-2, β-glucan, or high concentrations of LPS, expression of CR3 on NK cells increased significantly, but ≥4 hr of stimulation was required. Other cytokines (rIFN-γ, rIL-1, rIL-4, rIL-6, TNF-α) and rC5a had no significant effect on CR3 expression. Among NK cells, both the CD56bright and the CD56dim cells expressed CR3, and the expression of CR3 on both of these NK cell subsets was increased in a similar manner by PMA. However, rIL-2 stimulated a greater increase in CR3 expression on CD56bright cells than on CD56dim cells. These studies suggest that CR3 expressed by NK cells or cytotoxic T cells resembles phagocyte CR3 in that cellular activation stimulates increased surface expression of CR3 derived from cytoplasmic reserves of the receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ross GD: Function of neutrophils in host defense and immunity.In Immune System Accessory Cells, L Fornůsek, V Větvička (eds). Boca Raton, FL, CRC Press, 1992, pp 263–286

    Google Scholar 

  2. Hogg N: Roll, roll, roll your leucocyte gently down the vein. Immunol Today 13:113–115, 1992

    Google Scholar 

  3. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11–25, 1992

    Google Scholar 

  4. Berger M, O'Shea J, Cross AS, Folks TM, Chused TM, Brown EJ, Frank MM: Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 74:1566–1571, 1984

    Google Scholar 

  5. O'Shea JJ, Brown EJ, Seligmann BE, Metcalf JA, Frank MM, Gallin JI: Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol 134:2580–2587, 1985

    Google Scholar 

  6. Miller LJ, Bainton DF, Borregaard N, Springer TA: Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 80:535–544, 1987

    Google Scholar 

  7. Pryzwansky KB, Wyatt T, Reed W, Ross GD: Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis. Eur J Cell Biol 54:61–75, 1991

    Google Scholar 

  8. Ault KA, Springer TA: Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. J Immunol 126:359–364, 1981

    Google Scholar 

  9. Ortaldo JR, Sharrow SO, Timonen T, Herberman RB: Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 127:2401–2409, 1981

    Google Scholar 

  10. Hercend T, Reinherz EL, Meuer S, Schlossman SF, Ritz J: Phenotypic and functional heterogeneity of human cloned natural killer cells lines. Nature 301:158–160, 1983

    Google Scholar 

  11. Miller LJ, Schwarting R, Springer TA: Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation. J Immunol 137:2891–2900, 1986

    Google Scholar 

  12. De la Hera A, Alvarez-Mon M, Sánchez-Madrid F, Martinez-A C, Durantez A: Co-expression of Mac-1 and p150,95 on CD5+ B cells. Structural and functional characterization in a human chronic lymphocytic leukemia. Eur J Immunol 18:1131–1134, 1988

    Google Scholar 

  13. Gray JD, Horwitz DA: Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells. J Clin Invest 81:1247–1254, 1988

    Google Scholar 

  14. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL: Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CD3ɛ, δ proteins. J Exp Med 175:1055–1066, 1992

    Google Scholar 

  15. Werfel T, Witter W, Götze O: CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activation. J Immunol 147:2423–2427, 1991

    Google Scholar 

  16. Triozzi PL, Eicher DM, Rinehart JJ: Modulation of adhesion molecules on human large granular lymphocytes by interleukin-2in vivo andin vitro. Cell Immunol 140:295–303, 1992

    Google Scholar 

  17. Trinchieri G, Santoli D, Dee RR, Knowles BB: Anti-viral activity induced by culturing lymphocytes with tumorderived or virus-transformed cells. J Exp Med 147:1299–1313, 1978

    Google Scholar 

  18. Riccardi C, Herberman RB, Migliorati G: Role of IL-2 in growth and differentiation of cytotoxic cells.In Interleukin-2 and Killer Cells in Cancer, E Lotzová, RB Herberman (eds). Boca Raton, FL, CRC Press, 1990, pp 297–303

    Google Scholar 

  19. Herberman RB, Hiserodt J, Vujanovic N: Lymphokineactivated killer cell activity. Immunol Today 8:178–181, 1987

    Google Scholar 

  20. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ: Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement Inflamm 4:61–74, 1987

    Google Scholar 

  21. Eddy A, Newman SL, Cosio F, LeBien T, Michael A: The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody. Clin Immunol Immunopathol 31:371–389, 1984

    Google Scholar 

  22. Ross GD, Cain JA, Lachmann PJ: Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol 134:3307–3315, 1985

    Google Scholar 

  23. Myones BL, Dalzell JG, Hogg N, Ross GD: Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest 82:640–651, 1988

    Google Scholar 

  24. Bayer EA, Wilchek M: The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 26:1–45, 1980

    Google Scholar 

  25. Zarcone D, Cerruti G, Tenca C, Arancia G, Malorni W, Iosi F, Grossi CE: Human NK cell adhesion molecules (CAMs).In NK Cell Mediated Cytotoxicity: Receptors, Signaling, and Mechanisms, E Lotzová, RB Herberman (eds). Boca Raton, FL, CRC Press, 1992, pp 77–83

    Google Scholar 

  26. Bauume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J: Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol 22:1–6, 1992

    Google Scholar 

  27. Yancey KB, O'Shea J, Chused T, Brown E, Takahashi T, Frank MM, Lawley TJ: Human C5a modulates monocyte Fc and C3 receptor expression. J Immunol 135:465–470, 1985

    Google Scholar 

  28. Jones DH, Anderson DC, Burr BL, Rudloff HE, Smith CW, Krater SS, Schmalstieg FC: Quantitation of intracellular Mac-1 (CD11b/CD18) pools in human neutrophils. J Leukocyte Biol 44:535–544, 1988

    Google Scholar 

  29. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433, 1990

    Google Scholar 

  30. Lynn WA, Raetz CRH, Qureshi N, Golenbock DT: Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils: Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J Immunol 147:3072–3079, 1991

    Google Scholar 

  31. Tarkkanen J, Saksela E: Potentiation of human natural killer cell cytotoxicity bySalmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase. Infect Immun 59:2767–2773, 1991

    Google Scholar 

  32. Klimpel GR, Niesel DW, Asuncion M, Klimpel KD: Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria. Infect Immun 56:1436–1441, 1988

    Google Scholar 

  33. Lindemann RA: Bacterial activation of human natural killer cells: Role of cell surface lipopolysaccharide. Infect Immun 56:1301–1308, 1988

    Google Scholar 

  34. Roubey RAS, Ross GD, Merrill JT, Walton F, Reed W, Winchester RJ, Buyon JP: Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). J Immunol 146:3557–3562, 1991

    Google Scholar 

  35. Di Renzo L, Yefenof E, Klein E: The function of human NK cells is enhanced by β-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol 21:1755–1758, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, School of Medicine, University of Louisville, 40292, Louisville, Kentucky

    Satoshi Muto, Václav Větvička & Gordon D. Ross

Authors
  1. Satoshi Muto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Václav Větvička
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon D. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muto, S., Větvička, V. & Ross, G.D. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol 13, 175–184 (1993). https://doi.org/10.1007/BF00919970

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00919970

Key words

Search

Navigation